WallStreetZenWallStreetZen

NASDAQ: RMTI
Rockwell Medical Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Rockwell Medical revenue was $101.49M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $24.7M, down 12.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RMTI annual revenue was $101.5M, with 21.4% growth year-over-year.

RMTI past revenue growth

How has RMTI's revenue growth performed historically?

Company
21.38%
Industry
10.38%
Market
20.68%
RMTI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RMTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RMTI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RMTI revenue history

Current Revenue
$101.5M
Current Earnings
-$480.0k
Current Profit Margin
-0.5%

Be the first to know when RMTI announces revenue.

RMTI Revenue History By Year

RMTI Yearly RevenueRMTI RevenueRMTI ChangeRMTI Revenue Growth
2024-12-31$101.49M$17.88M+21.38%
2023-12-31$83.61M$10.80M+14.84%
2022-12-31$72.81M$10.88M+17.57%
2021-12-31$61.93M-$266.00k-0.43%
2020-12-31$62.20M$894.00k+1.46%
2019-12-31$61.30M-$2.09M-3.29%
2018-12-31$63.39M$6.09M+10.63%
2017-12-31$57.30M$4.02M+7.54%
2016-12-31$53.28M-$2.07M-3.73%
2015-12-31$55.35M$1.16M+2.14%
2014-12-31$54.19M$1.81M+3.45%
2013-12-31$52.38M$2.54M+5.09%
2012-12-31$49.84M$876.16k+1.79%
2011-12-31$48.97M-$10.59M-17.78%
2010-12-31$59.55M$4.83M+8.82%
2009-12-31$54.73M$3.06M+5.93%
2008-12-31$51.67M$8.62M+20.03%
2007-12-31$43.05M$14.41M+50.30%
2006-12-31$28.64M$943.90k+3.41%
2005-12-31$27.69M$9.75M+54.33%
2004-12-31$17.94M$2.97M+19.87%
2003-12-31$14.97M$3.47M+30.22%
2002-12-31$11.50M$2.48M+27.51%
2001-12-31$9.02M$1.56M+20.90%
2000-12-31$7.46M$768.09k+11.48%
1999-12-31$6.69M$1.42M+26.86%
1998-12-31$5.27M$1.95M+58.87%
1997-12-31$3.32MN/AN/A

1 of 2

Rockwell Medical Revenue FAQ

What was RMTI's revenue last quarter?

On Invalid Date, Rockwell Medical (NASDAQ: RMTI) reported Q4 2024 revenue of $24.67 million up 11.64% year over year. In the same quarter last year, Rockwell Medical's revenue was $22.09 million.

What was Rockwell Medical's revenue in 2024?

Rockwell Medical's annual revenue for the twelve months ending Dec 31, 2024 was $101.49 million, a 21.38% increase year over year.

How much does Rockwell Medical make in a day?

Based on Rockwell Medical annual revenue for the past five years, RMTI makes an average of $209,336.44 per day.

What was Rockwell Medical's annual revenue growth in the past year?

As of Q2 2025, Rockwell Medical's revenue has grown 21.38% year over year. This is 11.01 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Rockwell Medical's revenue in the past year totaled $101.49 million.

How much does Rockwell Medical make in a year?

Rockwell Medical's revenue by year for the past five years is:
  • Rockwell Medical's revenue for the twelve months ending Dec 31, 2024 was $101.49 million, a 21.38% increase year over year.
  • Rockwell Medical's annual revenue for Dec 31, 2023 was $83.61 million, a 14.84% increase from 2022.
  • Rockwell Medical's annual revenue for 2022 was $72.81 million, a 17.57% increase from 2021.
  • Rockwell Medical's annual revenue for 2021 was $61.93 million, a 0.43% decrease from 2020.
  • Rockwell Medical's annual revenue for 2020 was $62.20 million, a 1.46% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.